Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021:1328:361-376.
doi: 10.1007/978-3-030-73234-9_23.

The Effects of Ivy (Hedera helix) on Respiratory Problems and Cough in Humans: A Review

Hamed Baharara  1 , Ali Tafazoli Moghadam  2 , Amirhossein Sahebkar  3   4   5   6 , Seyed Ahmad Emami  7   8 , Tara Tayebi  9 , Amir Hooshang Mohammadpour  10   11
Affiliations
Review

The Effects of Ivy (Hedera helix) on Respiratory Problems and Cough in Humans: A Review

Hamed Baharara et al. Adv Exp Med Biol. 2021.

Abstract

Hedera helix (ivy) belongs to the genus Hedera of the Araliaceae family. The leaf of this plant has several active ingredients with medicinal uses. The active constituents of H. helix include monodesmoside α-hederin, hederacoside B, hederacoside C, and hederacoside D.H. helix leave have been used for the treatment of cough and respiratory problems, and now, other uses have emerged. As a medicinal plant, H. helix has been approved by the German Commission E due to its antispasmodic, spasmolytic, antimicrobial, anti-inflammatory, anthelmintic, antioxidative, antitumor, and antileishmanial activities. It comes with several formulations, including tablets, liquids, and topical ointments. In this review, we focus on the respiratory effects of tablet and liquid forms of H. helix.

Keywords: Araliaceae; Bronchitis; Cough; English ivy; Hedera helix; Respiratory problem.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Hofmann, D., Hecker, M., & Völp, A. (2003, January). Efficacy of dry extract of ivy leaves in children with bronchial asthma – a review of randomized controlled trials. Phytomedicine, 10(2–3), 213–220. - DOI
    1. Lutsenko, Y., Bylka, W., Matławska, I., & Darmohray, R. (2010). Hedera helix as a medicinal plant. Herba Polonica, 56(1), 83–96.
    1. Al-Snafi, D. A. E. (2018). Pharmacological and therapeutic activities of Hedera helix – A review. IOSR Journal of Pharmacy, 8, 41–53.
    1. Holzinger, F., & Chenot, J.-F. (2011). Systematic review of clinical trials assessing the effectiveness of ivy leaf (Hedera helix) for acute upper respiratory tract infections. Evidence-Based Complementary and Alternative Medicine, 2011, 1–9.
    1. Lang, C., Röttger-Lüer, P., & Staiger, C. (2015, August). A valuable option for the treatment of respiratory diseases: Review on the clinical evidence of the ivy leaves dry extract EA 575®. Planta Medica, 81(12–13), 968–974. - PubMed

LinkOut - more resources